EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro Anticancer Activity, Molecular Docking and Structure–Activity Relationship (SAR) Studies of Some Phenylamino Derivatives

Nivedya Prasad SreeNilayam, Jayanandan Abhithaj, Sruthi Remeshan, Shyma Makkaramkot, Muthipeedika Nibin Joy, Mallikarjuna R. Guda, Grigory V. Zyryanov, Karickal Raman Haridas

Biophysica · 03.08.2026 · 6 (4) · 70

DOI: 10.3390/biophysica6040070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biophysica, online erschienen am 03.08.2026. Verfasst von Nivedya Prasad SreeNilayam und 7 weiteren Autor:innen. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We herein report the anticancer activity and molecular docking studies of a series of amide derivatives of two nonsteroidal anti-inflammatory drugs (mefenamic acid and ibuprofen). The hypothesis of drug repurposing has been successfully employed to explore the promising anticancer activity of analogs of known anti-inflammatory agents. The compounds have been tested for their inhibitory potential against cervical cancer cell lines by MTT assay using 5-fluorouracil as the reference standard. Among the compounds screened, 3aa [2-(2,3-dimethylamino)phenyl)(1H-indol-1-yl)methanone] and 3ad [2-(2,3-dimethylphenylamino)phenyl)(9H-carbazol-9-yl)methanone] displayed good potency of less than 25 µg/mL half-maximal inhibitory concentration (IC50). The docking analysis has confirmed that molecule 3aa effectively binds to the active site of the target protein CDK2, with a docking score of −9.21 Kcal/mol and a binding energy of −46.44 Kcal/mol, involving a hydrogen bond with Ile 10. The molecule 3ad also exhibited a good glide score of −6.78 Kcal/mol with the binding energy of −45.90 Kcal/mol. As many of the tested compounds displayed promising potency against cervical cancer cell lines, our investigation revealed the importance of drug repurposing in the development of lead molecules in medicinal chemistry.

Förderung

  • Russian Science Foundation

Zitieren

APA

SreeNilayam, N. P., Abhithaj, J., Remeshan, S., Makkaramkot, S., Joy, M. N., Guda, M. R., Zyryanov, G. V., & Haridas, K. R. (2026). In Vitro Anticancer Activity, Molecular Docking and Structure–Activity Relationship (SAR) Studies of Some Phenylamino Derivatives. Biophysica, 6(4), 70. https://doi.org/10.3390/biophysica6040070

Vancouver

SreeNilayam NP, Abhithaj J, Remeshan S, Makkaramkot S, Joy MN, Guda MR, et al. In Vitro Anticancer Activity, Molecular Docking and Structure–Activity Relationship (SAR) Studies of Some Phenylamino Derivatives. Biophysica. 2026;6(4):70. doi:10.3390/biophysica6040070

BibTeX
@article{SreeNilayam2026,
  author = {SreeNilayam, Nivedya Prasad and Abhithaj, Jayanandan and Remeshan, Sruthi and Makkaramkot, Shyma and Joy, Muthipeedika Nibin and Guda, Mallikarjuna R. and Zyryanov, Grigory V. and Haridas, Karickal Raman},
  title = {In Vitro Anticancer Activity, Molecular Docking and Structure–Activity Relationship (SAR) Studies of Some Phenylamino Derivatives},
  journal = {Biophysica},
  year = {2026},
  volume = {6},
  number = {4},
  pages = {70},
  doi = {10.3390/biophysica6040070}
}
Kostenlos starten →